Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
The Stanford Intestinal Transplant Program offers advanced treatment strategies for patients with gastrointestinal dysfunction due to short bowel syndrome (or "short gut"). At Stanford Health Care, we provide personalized medical, nutrition and surgical therapies to improve intestinal function and meet the lifestyle needs of each patient.
Stanford surgeons have performed over 40 pediatric and adult intestinal transplants and more than 800 adult liver transplants, exceeding national outcomes.
Stanford is one of the pioneering institutions behind steroid-free immunosuppression, with the goal of diminishing the risk of diabetes, infection and hypertension. New research developments at the Stanford Institute for Immunity, Transplantation and Infection include the use of intestinal stem cells in transplantation and restoration of bowel function.
Transplant immunology and clinical immunosuppression studies at Stanford have led to innovative new approaches, including desensitization and stem cell developments.
HUMAN RIGHTS CAMPAIGN
Your doctor will request an evaluation by one of Stanford's transplant specialists, who will review your previous medical records and determine if additional tests are necessary.
Patients undergoing initial evaluation, medical follow-up before transplant, and post-transplant follow-up, both early and late, are seen in the intestinal transplant clinic. Patients are seen by appointment only.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.